CAROLYN HUTCHINSON: Open Payments
NPI 1124608641 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 46 payments from 6 companies in 2025. Trend: 2023 $23 · 2024 $136 · 2025 $1,529
Food & beverage: $1,529
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 30 | $927 |
| Gilead Sciences, Inc. | 9 | $453 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| ORPHALAN INC | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $15 |
Products named: REZDIFFRA, Livdelzi, XIFAXAN, CUVRIOR, ENTYVIO, OMVOH.
Industry payments across NY — which companies pay providers there.
